Published in Neurology on August 07, 2007
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation (2008) 1.22
Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation. Pediatrics (2009) 1.13
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis (2009) 1.10
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev (2009) 1.09
Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources. Pharmacol Ther (2009) 1.05
Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease. J Alzheimers Dis (2012) 1.04
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem (2008) 1.04
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis (2010) 1.01
Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans. Longev Healthspan (2012) 1.00
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) (2011) 0.99
Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study. J Alzheimers Dis (2011) 0.96
Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC Public Health (2011) 0.96
Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence. J Alzheimers Dis (2010) 0.95
Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons. Proc Natl Acad Sci U S A (2013) 0.94
Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS One (2014) 0.93
Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis (2011) 0.93
Effectiveness of topical caffeine in cataract prevention: studies with galactose cataract. Mol Vis (2010) 0.92
Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Adv Nutr (2013) 0.88
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease. Channels (Austin) (2014) 0.87
Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment. Neurobiol Dis (2014) 0.85
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? Biochem Soc Trans (2014) 0.85
Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease. Int J Alzheimers Dis (2011) 0.84
Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma. Clin Ophthalmol (2011) 0.82
Caffeine and alcohol intakes and overall nutrient adequacy are associated with longitudinal cognitive performance among U.S. adults. J Nutr (2014) 0.81
The role of adenosine in Alzheimer's disease. Curr Neuropharmacol (2009) 0.81
Protective effect of caffeine against high sugar-induced transcription of microRNAs and consequent gene silencing: a study using lenses of galactosemic mice. Mol Vis (2013) 0.80
Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging. Age (Dordr) (2013) 0.79
Coffee consumption and incident dementia. Eur J Epidemiol (2014) 0.79
Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer's disease. Mol Med Rep (2013) 0.78
Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory. Mol Psychiatry (2015) 0.78
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug? Curr Neuropharmacol (2015) 0.78
Lifespan Extension Induced by Caffeine in Caenorhabditis elegans is Partially Dependent on Adenosine Signaling. Front Aging Neurosci (2015) 0.78
Beneficial and detrimental role of adenosine signaling in diseases and therapy. J Appl Physiol (1985) (2015) 0.77
Habitual coffee consumption enhances attention and vigilance in hemodialysis patients. Biomed Res Int (2014) 0.77
Caffeine Content Labeling: A Missed Opportunity for Promoting Personal and Public Health. J Caffeine Res (2013) 0.77
Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors. Nat Commun (2016) 0.77
Our "energy-Ca(2+) signaling deficits" hypothesis and its explanatory potential for key features of Alzheimer's disease. Front Aging Neurosci (2014) 0.77
Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation. J Alzheimers Dis (2015) 0.76
Effect of coffee (caffeine) against human cataract blindness. Clin Ophthalmol (2016) 0.75
Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation. J Neuroimmune Pharmacol (2016) 0.75
Evaluation of the Anxiolytic and Antidepressant Activities of the Aqueous Extract from Camellia euphlebia Merr. ex Sealy in Mice. Evid Based Complement Alternat Med (2015) 0.75
Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review. Arch Med Sci (2016) 0.75
Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort. BMC Med (2017) 0.75
Caffeine and cognitive decline in elderly women at high vascular risk. J Alzheimers Dis (2013) 0.75
Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases. Mediators Inflamm (2017) 0.75
Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci (2016) 0.75
Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study. Sci Rep (2016) 0.75
Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation. Transl Psychiatry (2017) 0.75
The Safety of Ingested Caffeine: A Comprehensive Review. Front Psychiatry (2017) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc (1995) 3.51
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ (2010) 3.37
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Restriction in complex activities of daily living in MCI: impact on outcome. Neurology (2006) 2.64
A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol (1997) 2.50
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke (1991) 2.19
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia (1992) 2.05
Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique. Antimicrob Agents Chemother (1992) 1.96
Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol (1994) 1.96
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
Intake of flavonoids and risk of dementia. Eur J Epidemiol (2000) 1.85
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) (1997) 1.77
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol (1994) 1.64
Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol (1983) 1.64
Body mass index and incidence of dementia: the PAQUID study. Neurology (2003) 1.63
Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol (2007) 1.60
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc (1992) 1.52
The Paquid epidemiological program on brain ageing. Neuroepidemiology (1992) 1.51
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. J Med Chem (2000) 1.50
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50
Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study. Neurology (2011) 1.48
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
[The Paquid research program on the epidemiology of dementia. Methods and initial results]. Rev Neurol (Paris) (1991) 1.43
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol (2001) 1.42
Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology (2009) 1.41
Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol (1996) 1.41
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology (2012) 1.41
Functional impairment in instrumental activities of daily living: an early clinical sign of dementia? J Am Geriatr Soc (1999) 1.40
Initial factors predicting functional performance in patients with traumatic tetraplegia. Paraplegia (1990) 1.40
CSF biomarkers in posterior cortical atrophy. Neurology (2011) 1.39
Frequency of severe attacks in migraine sufferers of the Gazel cohort. Cephalalgia (1997) 1.38
Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials. J Nutr Health Aging (2010) 1.36
Malarial lipids. An overview. Subcell Biochem (1992) 1.35
Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol (2000) 1.30
Cognitive process in preclinical phase of dementia. Brain (1998) 1.29
Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology (1999) 1.29
Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport. Antimicrob Agents Chemother (1986) 1.27
Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol (1998) 1.25
Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program. Neuroepidemiology (1994) 1.24
A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom (2001) 1.24
Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand (1994) 1.23
Occupation during life and risk of dementia in French elderly community residents. J Neurol Neurosurg Psychiatry (2001) 1.22
Subjective health and mortality in French elderly women and men. J Gerontol B Psychol Sci Soc Sci (1999) 1.21
Electrogram patterns predictive of successful catheter ablation of accessory pathways. Value of unipolar recording mode. Circulation (1991) 1.21
Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A (1996) 1.21
Biosynthesis and dynamics of lipids in Plasmodium-infected mature mammalian erythrocytes. Blood Cells (1990) 1.21
A hierarchical model of domains of disablement in the elderly: a longitudinal approach. Disabil Rehabil (2000) 1.21
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol (2001) 1.19
Ischaemic stroke subtypes and associated risk factors: a French population based study. J Neurol Neurosurg Psychiatry (2008) 1.18
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci U S A (2001) 1.17
Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. Arch Ophthalmol (2001) 1.15
Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis. J Med Chem (1997) 1.15
Spinal cord injuries--epidemiology in Portugal's central region. Spinal Cord (1998) 1.12
Disability and handicap 5 years after a head injury: a population-based study. J Clin Epidemiol (1997) 1.12
Relationship between body mass index and different domains of disability in older persons: the 3C study. Int J Obes Relat Metab Disord (2004) 1.12
Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation. Biochem J (1997) 1.12
Social relations and depressive symptomatology in a sample of community-dwelling French older adults. Psychol Aging (1997) 1.12
Marital status and risk of Alzheimer's disease: a French population-based cohort study. Neurology (1999) 1.11
Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res (2009) 1.11
Neuropsychologic effects of long-term exposure to pesticides: results from the French Phytoner study. Environ Health Perspect (2001) 1.10
Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey. J Am Geriatr Soc (1997) 1.10
[Development of a neurological score for the clinical evaluation of sylvian infarctions]. Presse Med (1983) 1.09
Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. J Clin Epidemiol (1996) 1.08
Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging (2004) 1.08
Differential in vitro activities of ionophore compounds against Plasmodium falciparum and mammalian cells. Antimicrob Agents Chemother (1996) 1.07
Principal lifetime occupation and cognitive impairment in a French elderly cohort (Paquid). Am J Epidemiol (1992) 1.07
Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds. Antimicrob Agents Chemother (1997) 1.06